The Cardio-share Telemedicine Cross-sector Collaboration Model for Managing Vulnerable Patients W… (NCT06176131) | Clinical Trial Compass
RecruitingNot Applicable
The Cardio-share Telemedicine Cross-sector Collaboration Model for Managing Vulnerable Patients With Heart Failure
Denmark300 participantsStarted 2024-01-01
Plain-language summary
The goal of this observational study is to explore the potential of implementing a telemedicine-based cross-sector collaboration model to manage patients with frequent admissions with decompensated heart failure. The main question(s) it aims to answer are:
* Characterization of conditions that make these patients vulnerable
* Description of key-elements that makes possible to manage the patients with the cardio-share model
Participants are:
* Patients - will be helped to use the available telemedicine tools
* General Practitioners - will be offered teleconferences with cardiologists (chat and video) on demand
* Community health workers (caregivers at the patient home or in elderly home) - will be guided to assist the patients to use the available telemedicine tools Researchers will compare readmission rates (primary outcome) and quality of life of patients where the cardio-share management model is successfully implemented one year before and after the implementation.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Patients admitted with acute decompensated heart failure AND:
* with previous admission with decompensated heart failure in the three-month period prior to the current admission or
* who have two or more admissions in the 6 months prior to the current admission.
Exclusion Criteria:
* Patients who
* have refused to share their data for health-quality projects
* have already ongoing telemedicine management for heart failure
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Days out-of-hospital
Timeframe: six months
Trial details
NCT IDNCT06176131
SponsorUniversity Hospital Bispebjerg and Frederiksberg